Locations:

Tag: myelofibrosis-associated anemia

March 18, 2025/Cancer/News & Insight

Personalizing Treatment of Myelofibrosis-Associated Anemia

Combination therapy may help address underlying disease

June 13, 2023/Cancer/Research

Luspatercept Shows Promise as Treatment for Anemia in Patients With Myelofibrosis

Approach resulted in transfusion independence and durable anemia response

March 23, 2022/Cancer/Blood Cancers

Experimental Drug Shows Promise for Alleviating Myelofibrosis-Associated Anemia

Momelotinib, a new JAK inhibitor, inches closer to market approval

January 7, 2021/Cancer/Blood Cancers

Pacritinib Moves Closer to FDA Approval for Myelofibrosis

Dose-finding trial adds to evidence of efficacy

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

December 9, 2019/Cancer/Research

Treatment for Myelofibrosis-Associated Anemia on the Horizon

Interim results of phase 2 trial are promising

BackPage 1 of 1Next